China Isotope & Radiation -H (1763.HK) traded down -3.5 % during a 24 hours period ending at 02:19 AM Central Europe on Wednesday 28th. One China Isotope & Radiation -H stock can currently be bought for about HKD 12.29 on popular exchanges. Current supply of China Isotope & Radiation -H stocks is 80 mn. China Isotope & Radiation -H has a current market capitalization of HKD 3.7 bn and approximately HKD 4.3 mn worth of China Isotope & Radiation -H was traded on exchanges in the last 24 hours. Since last month end, China Isotope & Radiation -H has traded -14.48 % down. Simple moving average of last 200 days is at HKD 18.13. The highest price of past 52 weeks was recorded at HKD 25 on 11/12/2025. 52 weeks low was at HKD 11 on 10/22/2026.

Here is how related stocks have performed in the past 24 hours:

  • Zhuhai Huajin Capital L (000532.SZ) traded flat 0 % and now trades at CNY 10.54. Zhuhai Huajin Capital L has a market capitalisation of CNY 3.8 bn. Current price/earnings ratio for Zhuhai Huajin Capital L is 21.04.

  • Zhejiang Zhengte (001238.SZ) traded flat 0 % and now trades at CNY 23.19. Current market capitalisation for Zhejiang Zhengte is CNY 3.8 bn.

  • Mega P&c Advanced Materials (603062.SS) traded flat 0 % and now trades at CNY 34.42. Mega P&c Advanced Materials has a market capitalisation of CNY 3.8 bn. Current price/earnings ratio for Mega P&c Advanced Materials is 29.21.

  • Guangdong Mingzhu (600382.SS) traded flat 0 % and now trades at CNY 5.33. Current market capitalisation for Guangdong Mingzhu is CNY 3.8 bn. Current price/earnings ratio for Guangdong Mingzhu is 20.73.

  • Yatai (000691.SZ) traded flat 0 % and now trades at CNY 7.51. Yatai has a market capitalisation of CNY 3.8 bn.

About China Isotope & Radiation -H

China Isotope & Radiation Corporation is a health care equipment and supplies industry player that specializes in the development, manufacturing, distribution, and various related services associated with nuclear products. The company offers nuclear reactors and cyclotrons, radio-pharmaceuticals, radioactive sources, radiation engineering, and other related services, which it markets globally.